Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 2
1999 2
2001 1
2003 1
2006 2
2007 3
2008 2
2009 1
2010 2
2011 6
2013 2
2014 3
2015 1
2016 1
2017 1
2018 2
2019 3
2020 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Glucose transporter expression in developing fetal lungs and lung neoplasms.
Ito T, Noguchi Y, Udaka N, Kitamura H, Satoh S. Ito T, et al. Histol Histopathol. 1999 Jul;14(3):895-904. doi: 10.14670/HH-14.895. Histol Histopathol. 1999. PMID: 10425560 Review.
GLUT1 expression in adenocarcinoma of the lung is correlated with reduced cell differentiation, larger tumor size and positive lymph node metastasis. A few cases of lung carcinoma show positive staining for GLUT3 and GLUT4. Thus, expression of some facilitative glucose tra …
GLUT1 expression in adenocarcinoma of the lung is correlated with reduced cell differentiation, larger tumor size and positive lymph node me …
Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.
Ogawa J, Inoue H, Koide S. Ogawa J, et al. Int J Cancer. 1997 Apr 22;74(2):189-92. doi: 10.1002/(sici)1097-0215(19970422)74:2<189::aid-ijc9>3.0.co;2-v. Int J Cancer. 1997. PMID: 9133454 Free article.
To examine the role of elevated glucose uptake in lung cancer, we performed PCR amplification of 2 facilitative glucose transporter genes (GLUT1 and GLUT3) and immunohistochemical staining for GLUT1, proliferating cell nuclear antigen (PCNA), and sialyl Lewis x (sLe(x)) on …
To examine the role of elevated glucose uptake in lung cancer, we performed PCR amplification of 2 facilitative glucose transporter genes (G …
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Contat C, Ancey PB, Zangger N, Sabatino S, Pascual J, Escrig S, Jensen L, Goepfert C, Lanz B, Lepore M, Gruetter R, Rossier A, Berezowska S, Neppl C, Zlobec I, Clerc-Rosset S, Knott GW, Rathmell JC, Abel ED, Meibom A, Meylan E. Contat C, et al. Elife. 2020 Jun 23;9:e53618. doi: 10.7554/eLife.53618. Elife. 2020. PMID: 32571479 Free PMC article.
In a genetically-engineered mouse model of lung adenocarcinoma, we show that the deletion of only one highly expressed glucose transporter, Glut1 or Glut3, in cancer cells does not impair tumor growth, whereas their combined loss diminishes tumor development. (18)F-FDG-PET …
In a genetically-engineered mouse model of lung adenocarcinoma, we show that the deletion of only one highly expressed glucose transporter, …
Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Do SK, Choi SH, Lee SY, Choi JE, Hong MJ, Kang HG, Lee WK, Lee EB, Shin KM, Jeong JY, Lee YH, Seo H, Yoo SS, Lee J, Cha SI, Kim CH, Seok Y, Cho S, Jheon S, Park JY. Do SK, et al. Gene. 2019 Jun 30;703:58-64. doi: 10.1016/j.gene.2019.04.013. Epub 2019 Apr 4. Gene. 2019. PMID: 30954677
This study was conducted to explore whether polymorphisms of glucose transporter 3 (GLUT3) gene affect the prognosis of patients with non-small cell lung cancer (NSCLC) after surgical resection. Four single nucleotide polymorphisms (SNPs) in GLUT3 were investigated …
This study was conducted to explore whether polymorphisms of glucose transporter 3 (GLUT3) gene affect the prognosis of patients with …
[Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance].
Lu GH, Zhong XJ, Ding W, Zhou JY. Lu GH, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008 Mar;37(2):176-81. doi: 10.3785/j.issn.1008-9292.2008.02.013. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18422279 Chinese.
OBJECTIVE: To investigate the expression of glucose transporter (Glut)1, Glut3, and hypoxia inducible factor (HIF)-1 alpha in human non-small cell lung carcinoma (NSCLC), and its clinical significance. METHODS: Specimens of cancer tissues and paracancerous lung tissues fro …
OBJECTIVE: To investigate the expression of glucose transporter (Glut)1, Glut3, and hypoxia inducible factor (HIF)-1 alpha in human n …
IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
Shimizu M, Tanaka N. Shimizu M, et al. Oncogene. 2019 Feb;38(9):1520-1533. doi: 10.1038/s41388-018-0533-4. Epub 2018 Oct 10. Oncogene. 2019. PMID: 30305725
We also showed that IL-8 stimulation of colon and lung cancer cells-induced glucose uptake and expressions of glucose transporter 3 (GLUT3) and glucosamine fructose-6-phosphate aminotransferase (GFAT), a regulator of glucose flux to the hexosamine biosynthetic pathway, res …
We also showed that IL-8 stimulation of colon and lung cancer cells-induced glucose uptake and expressions of glucose transporter 3 (GLUT …
Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M. Kurata T, et al. Jpn J Cancer Res. 1999 Nov;90(11):1238-43. doi: 10.1111/j.1349-7006.1999.tb00702.x. Jpn J Cancer Res. 1999. PMID: 10622535 Free PMC article.
The aim of this study was to investigate the gene expression levels of the GLUT family, especially GLUT1, GLUT3, and GLUT5 in primary lung cancer, metastatic liver tumors, and normal lung tissues, and to compare the expression levels of primary and metastatic tumors with t …
The aim of this study was to investigate the gene expression levels of the GLUT family, especially GLUT1, GLUT3, and GLUT5 in primary …
Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response.
Na KJ, Choi H, Oh HR, Kim YH, Lee SB, Jung YJ, Koh J, Park S, Lee HJ, Jeon YK, Chung DH, Paeng JC, Park IK, Kang CH, Cheon GJ, Kang KW, Lee DS, Kim YT. Na KJ, et al. Theranostics. 2020 Jul 25;10(21):9579-9590. doi: 10.7150/thno.48954. eCollection 2020. Theranostics. 2020. PMID: 32863946 Free PMC article.

Results: ImmuneScore showed a negative correlation with GLUT1 (r = -0.70, p < 0.01) and a positive correlation with GLUT3 (r = 0.39, p < 0.01) in LUSC. Single-cell RNA-seq showed GLUT1 and GLUT3 were mostly expressed in cancer and immune cells, respectively. .

…

Results: ImmuneScore showed a negative correlation with GLUT1 (r = -0.70, p < 0.01) and a positive correlation with GLUT3 (r = 0.3

…
Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival.
Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Younes M, et al. Cancer. 1997 Sep 15;80(6):1046-51. doi: 10.1002/(sici)1097-0142(19970915)80:6<1046::aid-cncr6>3.0.co;2-7. Cancer. 1997. PMID: 9305704
RESULTS: Of the 289 cases, 49 (17%) were negative for both Glut1 and Glut3, 239 (83%) were Glut1 positive, 61 (21%) were Glut3 positive, 179 (62%) were positive for Glut1 but negative for Glut3, 1 (0.3%) was positive for Glut3 but negative for Glut1, a …
RESULTS: Of the 289 cases, 49 (17%) were negative for both Glut1 and Glut3, 239 (83%) were Glut1 positive, 61 (21%) were Glut3 …
34 results